A Study of Stapokibart Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) .

NCT07483268 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2026-03-19

No results posted yet for this study

Summary

This study is a open label, prospective study to evaluate the safety of Stapokibart Injection in subjects with CRSwNP.

Conditions

  • CRSWNP

Interventions

BIOLOGICAL

Stapokibart

subcutaneous injection

Sponsors & Collaborators

  • Chengdu Kangnuoxing Biopharma,Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2027-12-31
Completion
2028-02-29

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07483268 on ClinicalTrials.gov